Skip to content

DVLP Medicines

Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing

First Investment: 2022

The effort required to build a traditional phar­ma­ceu­tical or biotech company is part of what makes drug development so slow and expensive. The DVLP Medicines platform digitizes and streamlines the process, supporting project-focused work around individual molecules. On the platform, project leaders can recruit investors, connect with vendors, and meet regulatory require­ments, while smart contracts provide an immutable record at every turn. DVLP will use the platform to rescue desperately needed but stranded medicines from broken therapeutic markets, such as new antibiotics to combat antimi­cro­bial resistance and ther­a­peu­tics that treat rare diseases.

Explore Companies